Compile Data Set for Download or QSAR
maximum 50k data
Found 50 Enz. Inhib. hit(s) with all data for entry = 8599
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406357(4-Fluoro-2-((3R,4S or 3S,4R)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  650nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406406(US10336733, Example 50)
Affinity DataEC50:  67nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406359(4-Fluoro-2-((3R,4S or 3S,4R)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  1.72E+3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406360(4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  93nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406361(N-(Cyclopropylsulfonyl)-2-((3R,4S or 3S,4R)-4-hydr...)
Affinity DataEC50:  2.17E+3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406362(N-(Cyclopropylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydr...)
Affinity DataEC50:  28nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406363(2-((3R,4S or 3S,4R)-4-Hydroxy-3-(pyridin-2-ylmethy...)
Affinity DataEC50:  1.27E+3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406364(2-((3S,4R or 3R,4S)-4-Hydroxy-3-(pyridin-2-ylmethy...)
Affinity DataEC50:  22nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406365(4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  4nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406366(4-Fluoro-2-((3R,4S or 3S,4R)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  870nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406367(N-(tert-Butylsulfonyl)-2-((3R,4S or 3S,4R)-4-hydro...)
Affinity DataEC50:  144nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406368(N-(tert-Butylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydro...)
Affinity DataEC50:  17nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406369(N-(tert-Butylsulfonyl)-4-fluoro-2-((3R,4S or 3S,4R...)
Affinity DataEC50:  441nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406370(N-(tert-Butylsulfonyl)-4-fluoro-2-((3S,4R or 3R,4S...)
Affinity DataEC50:  2nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406371(N-(Cyclopropylsulfonyl)-4-fluoro-2-((3R,4S or 3S,4...)
Affinity DataEC50:  480nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406372(N-(Cyclopropylsulfonyl)-4-fluoro-2-((3S,4R or 3R,4...)
Affinity DataEC50:  4nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406373(2-((3,4-trans)-4-Hydroxy-3-(pyridin-2-ylmethyl)chr...)
Affinity DataEC50:  24nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406374(N-((Cyclopropylmethyl)sulfonyl)-2-((3,4-trans)-4-h...)
Affinity DataEC50:  23nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406375(N-(Cyclopentylsulfonyl)-2-((3,4-trans)-4-hydroxy-3...)
Affinity DataEC50:  48nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406376(2-((3,4-trans)-4-Hydroxy-3-(pyridin-2-ylmethyl)chr...)
Affinity DataEC50:  44nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406377(2-((3R,4S or 3S,4R)-3-Benzyl-4-hydroxychroman-7-yl...)
Affinity DataEC50:  2.04E+3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406378(2-((3S,4R or 3R,4S)-3-Benzyl-4-hydroxychroman-7-yl...)
Affinity DataEC50:  15nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406379(2-((3R,4S or 3S,4R)-3-Benzyl-4-hydroxychroman-7-yl...)
Affinity DataEC50:  2.82E+3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406380(2-((3S,4R or 3R,4S)-3-Benzyl-4-hydroxychroman-7-yl...)
Affinity DataEC50:  17nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406381(US10336733, Example 25)
Affinity DataEC50:  16nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406382(US10336733, Example 26)
Affinity DataEC50:  770nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406383(US10336733, Example 27)
Affinity DataEC50:  26nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406384(2-(Rac-trans)-4-Hydroxy-3-((1-methyl-1H-pyrazol-5-...)
Affinity DataEC50:  360nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406385(2-((Rac-trans)-4-Hydroxy-3-((5-methyl-1,3,4-thiadi...)
Affinity DataEC50:  740nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406386(2-((Rac-trans)-3-((1-ethyl-1H-pyrazol-5-yl)methyl)...)
Affinity DataEC50:  538nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406387(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  556nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406388(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  11nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406389(N-(tert-Butylsulfonyl)-2-((3R,4S or 3S,4R)-4-hydro...)
Affinity DataEC50:  808nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406388(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  9nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406391(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  95nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406392(N-(tert-Butylsulfonyl)-2-((rac-trans)-3-((1-ethyl-...)
Affinity DataEC50:  81nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406392(N-(tert-Butylsulfonyl)-2-((rac-trans)-3-((1-ethyl-...)
Affinity DataEC50:  36nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406394(N-(tert-Butylsulfonyl)-2-((3R,4S or 3S,4R)-3-((1-e...)
Affinity DataEC50:  1.16E+3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406395(2-((Rac-cis)-3-([1,1′-Biphenyl]-4-ylmethyl)-...)
Affinity DataEC50:  37nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406396(2-((Rac-trans)-3-([1,1′-Biphenyl]-4-ylmethyl...)
Affinity DataEC50:  9nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406396(2-((Rac-trans)-3-([1,1′-Biphenyl]-4-ylmethyl...)
Affinity DataEC50:  11nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406398(US10336733, Example 42)
Affinity DataEC50:  35nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406399(US10336733, Example 43)
Affinity DataEC50:  19nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406400(US10336733, Example 44)
Affinity DataEC50:  60nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406401(US10336733, Example 45)
Affinity DataEC50:  3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406402(2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...)
Affinity DataEC50:  15nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406402(2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...)
Affinity DataEC50:  75nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406404(N-(tert-Butylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydro...)
Affinity DataEC50:  5nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406405(US10336733, Example 49)
Affinity DataEC50:  154nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406358(4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  6nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent